Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

2C3 antibody inhibits tumor growth by 75%

Feb. 5, 2003

New phase I trial for VNP-40101M in solid tumors

Feb. 5, 2003

Pyrimidine-based tyrosine kinase inhibitors covered by Merck patent

Feb. 5, 2003

Arizona State U. researchers design new combretastatin A3 prodrugs

Feb. 5, 2003

Cytovia scientists design caspase activators and apoptosis inducers

Feb. 5, 2003

Enrollment completed in phase III Tarceva trial in refractory NSCLC

Feb. 4, 2003

Idec and Biogen to codevelop three Biogen oncology therapeutics

Feb. 4, 2003

New antitumor daunorubicin derivatives designed by Pharmacia

Feb. 4, 2003

Corixa and GSK form cancer vaccine collaboration

Feb. 3, 2003

ATN-161 enters the clinic

Feb. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...